Palisade Bio IncPALI
Price$1.43

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $0TTM through 31 Mar 2026
Net Income -$16.8MTTM through 31 Mar 2026
Free Cash Flow -$12.4MTTM through 31 Mar 2026

Margins

Current

Returns

-7.5%ROE
-7.2%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio23.71x
Net Debt-$132.6Mnet cash position
Cash & Equivalents$132.6M

Quality Metrics

Earnings-Beat Rate0.0%

Dividend

No dividend

Segment Performance

No segment data available.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.